Table 2

SNPs showing significant association with aGVHD

LocusGenes in LD blockAnalysis typeMost significant SNP in the regionTest statistics in GWASCompeting risk regression analysis among the entire cohort
Log-rank testLog-rank trend test
Subject*Eventdb SNP IDPosition (hg19)Allele (frequency, %)Mismatch frequency (among the entire cohort), %χ2Pχ2PHR (95% CI)P
6p21.32 HLA-DPB1, HLA-DPA1 All II-IV aGVHD rs6937034 (On chip) 33 079 766 A/G (32.3) 26.5 (—) 37.5 9.06 × 10−10 29.1 6.76 × 10−8 1.65 (1.40-1.95) 4.50 × 10−9 
12p12.1 KRAS, LYRM5, CASC1, LRMP DQB1 *06:01 III-IV aGVHD rs17473423 (On chip) 25 362 777 A/G (13.1) 20.5 (10.2) 37.5 9.34 × 10−10 48.9 2.73 × 10−12 2.44 (1.88-3.15) 1.20 × 10−11 
*52:01 C/T (13.1) 19.7 (7.6) 34.4 4.42 × 10−9 45.1 1.87 × 10−11 2.48 (1.88-3.26) 8.40 × 10−11 
*12:02 rs7976254 (On chip) 25 256 354 C/T (13.1) 19.7 (7.6) 34.4 4.42 × 10−9 45.1 1.87 × 10−11 2.48 (1.88-3.26) 8.40 × 10−11 
DRB1 *15:02 C/T (13.0) 19.8 (7.4) 32.5 1.20 × 10−8 43.0 5.47 × 10−11 2.47 (1.87-3.25) 1.40 × 10−10 
9q31.3 None *44:03 III-IV aGVHD rs9657655 (Imputed) 113 391 486 A/T (5.4) 12.3 (2.5) 38.0 7.00 × 10−10 33.1 8.79 × 10−9 3.31 (2.02-5.42) 2.10 × 10−6 
*14:03 A/T (5.4) 12.3 (2.5) 38.0 7.00 × 10−10 33.1 8.79 × 10−9 3.31 (2.02-5.42) 2.10 × 10−6 
*33:03§ A/T (5.3) 13.2 (2.7) 32.1 1.46 × 10−8 28.2 1.09 × 10−7 3.29 (2.03-5.32) 1.30 × 10−6 
6q16.2 None *07:02 III-IV aGVHD rs12206927 (Imputed) 99 613 136 A/G (9.6) 11.% (2.5) 33.5 6.97 × 10−9 31.2 2.34 × 10−8 3.68 (2.40-5.64) 2.50 × 10−9 
LocusGenes in LD blockAnalysis typeMost significant SNP in the regionTest statistics in GWASCompeting risk regression analysis among the entire cohort
Log-rank testLog-rank trend test
Subject*Eventdb SNP IDPosition (hg19)Allele (frequency, %)Mismatch frequency (among the entire cohort), %χ2Pχ2PHR (95% CI)P
6p21.32 HLA-DPB1, HLA-DPA1 All II-IV aGVHD rs6937034 (On chip) 33 079 766 A/G (32.3) 26.5 (—) 37.5 9.06 × 10−10 29.1 6.76 × 10−8 1.65 (1.40-1.95) 4.50 × 10−9 
12p12.1 KRAS, LYRM5, CASC1, LRMP DQB1 *06:01 III-IV aGVHD rs17473423 (On chip) 25 362 777 A/G (13.1) 20.5 (10.2) 37.5 9.34 × 10−10 48.9 2.73 × 10−12 2.44 (1.88-3.15) 1.20 × 10−11 
*52:01 C/T (13.1) 19.7 (7.6) 34.4 4.42 × 10−9 45.1 1.87 × 10−11 2.48 (1.88-3.26) 8.40 × 10−11 
*12:02 rs7976254 (On chip) 25 256 354 C/T (13.1) 19.7 (7.6) 34.4 4.42 × 10−9 45.1 1.87 × 10−11 2.48 (1.88-3.26) 8.40 × 10−11 
DRB1 *15:02 C/T (13.0) 19.8 (7.4) 32.5 1.20 × 10−8 43.0 5.47 × 10−11 2.47 (1.87-3.25) 1.40 × 10−10 
9q31.3 None *44:03 III-IV aGVHD rs9657655 (Imputed) 113 391 486 A/T (5.4) 12.3 (2.5) 38.0 7.00 × 10−10 33.1 8.79 × 10−9 3.31 (2.02-5.42) 2.10 × 10−6 
*14:03 A/T (5.4) 12.3 (2.5) 38.0 7.00 × 10−10 33.1 8.79 × 10−9 3.31 (2.02-5.42) 2.10 × 10−6 
*33:03§ A/T (5.3) 13.2 (2.7) 32.1 1.46 × 10−8 28.2 1.09 × 10−7 3.29 (2.03-5.32) 1.30 × 10−6 
6q16.2 None *07:02 III-IV aGVHD rs12206927 (Imputed) 99 613 136 A/G (9.6) 11.% (2.5) 33.5 6.97 × 10−9 31.2 2.34 × 10−8 3.68 (2.40-5.64) 2.50 × 10−9 

LD, linkage disequilibrium.

*

“All” refers to no stratification being applied; subsequent entries in this column were DPB1 allele mismatch stratified.

Frequency of the second listed allele.

Genotype mismatch frequency in GVH direction.

§

For each locus, all the results from the same group indicated in supplemental Table 1 were listed in this table, if they were not significant.

Close Modal

or Create an Account

Close Modal
Close Modal